Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
COSMO BIO, Ordinary Profit Unexpectedly Turn to Loss for Last Fiscal Year, 30% Decrease in The Current Fiscal Year
3386 COSMO BIO COMPANY, LIMITED 【J-GAAP】
Earnings ReportCOSMO BIO COMPANY, LIMITED <3386> [TSE Std] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit for the fiscal year ended December 2025 expanded to 34.3% from the previous period to 489 million yen, falling below the forecast of 580 million yen. However, for the fiscal year ending December 2026, the consolidated ordinary profit is expected to drop by 30.5% from the previous period to 340 million yen.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit/loss turned to a profit of 120 million yen (compared to a loss of 20 million yen in the same period last year). The operating profit/loss margin significantly improved from -1.9% in the same period last year to 2.4%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 9,340 | 519 | 653 | 442 | 76.0 | 30 | Feb 14, 2024 | J-GAAP |
| Dec, 2024 | 10,037 | 318 | 364 | 262 | 45.1 | 50 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 | 10,766 | 343 | 489 | 337 | 59.3 | 50 | Feb 13, 2026 | J-GAAP |
| YoY | +7.3% | +7.9% | +34.3% | +28.6% | +31.5% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2025 Guidance | 10,700 | 490 | 580 | 430 | 75.8 | 50 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 Results | 10,766 | 343 | 489 | 337 | 59.3 | 50 | Feb 13, 2026 | J-GAAP |
| Revision Rate | +0.6% | -30.0% | -15.7% | -21.6% | -21.8% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 5,402 | 276 | 343 | 250 | 44.0 | 25 | Aug 5, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | 5,700 | 170 | 200 | 130 | 22.9 | 25 | Feb 13, 2026 | J-GAAP |
| YoY | +5.5% | -38.4% | -41.7% | -48.0% | -48.0% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2024 | 10,037 | 318 | 364 | 262 | 45.1 | 50 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 | 10,766 | 343 | 489 | 337 | 59.3 | 50 | Feb 13, 2026 | J-GAAP |
| Dec, 2026 Guidance | 11,400 | 270 | 340 | 220 | 38.8 | 50 | Feb 13, 2026 | J-GAAP |
| YoY | +5.9% | -21.3% | -30.5% | -34.7% | -34.6% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 2,628 | -51 | -20 | -29 | -5.0 | -1.9 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 3,093 | 273 | 293 | 212 | 37.2 | 8.8 | May 9, 2025 | J-GAAP |
| Apr - Jun, 2025 | 2,309 | 3 | 50 | 38 | 6.7 | 0.1 | Aug 5, 2025 | J-GAAP |
| Jul - Sep, 2025 | 2,483 | -1 | 26 | 22 | 3.9 | 0.0 | Nov 7, 2025 | J-GAAP |
| Oct - Dec, 2025 | 2,881 | 68 | 120 | 65 | 11.4 | 2.4 | Feb 13, 2026 | J-GAAP |
| YoY | +9.6% | - | - | - | - |
Related Articles
AVIX Inc, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 54%, Oct-Dec Ordinary Profit Turns to Loss
fonfun, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.2 times, Oct-Dec Ordinary Profit Increases by 3.8 times
Kohjin Bio, Ordinary Profit Forecast for the Fiscal Year Revised Downward to an Unexpected 56% Decrease, Dividend Revised down by 15 Yen
Will Smart, Returning to Profitability This Year
Retty, Oct-Dec (1Q) Ordinary Profit Turns to Profit
e-LogiT, Apr-Dec (Cumulative 3Q) Net Income Turns to Loss, Oct-Dec Net Income Decreases by 53%
KPP GROUP, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 41%
IID, First Half Ordinary Profit Decreases by 27%, Oct-Dec Ordinary Profit Decreases by 8%
Toho Zinc, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 94%
Bridge Consulting, Oct-Dec (1Q) Ordinary Profit Increases by 15%